C
Christina Nowack
Researcher at Bayer
Publications - 27
Citations - 3064
Christina Nowack is an academic researcher from Bayer. The author has contributed to research in topics: Finerenone & Kidney disease. The author has an hindex of 16, co-authored 24 publications receiving 1751 citations. Previous affiliations of Christina Nowack include Bayer HealthCare Pharmaceuticals & Bayer Corporation.
Papers
More filters
Journal ArticleDOI
Masked and Nocturnal Hypertension in the ARTS-DN ABPM Sub-Study with Finerenone.
Journal ArticleDOI
Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
TL;DR: Although Dr Feng and colleagues are correct that change in UACR at day 90 was the primary end point, it is understood this is not consistent with any valid renal outcome and is a marker of inflammation and cardiovascular risk rather than renal injury.
Journal ArticleDOI
Position Statement from ADA/AACE/EASD/TES in Response to a Recently Published Letter to the Editor in The Lancet and an Editorial Addressing the Israeli-Palestinian Fighting in Gaza
Wei Deng,Yile Ren,Xuebing Feng,Genhong Yao,Weiwei Chen,Yue Sun,Hengjin Wang,Xiang Gao,Lingyun Sun,Luis M. Ruilope,Peter Rossing,Rajiv Agarwal,Juliana C. Chan,Mark E. Cooper,Ron T. Gansevoort,Hermann Haller,Giuseppe Remuzzi,Roland E. Schmieder,Christina Nowack,Anna C. Ferreira,Alexander Pieper,Nina Kimmeskamp-Kirschbaum,George L. Bakris,Sharon M. Moe,Ranjani N. Moorthi,Cheryl L.H. Armstrong,Kevin Janda,Kristen Ponsler-Sipes,John R. Asplin,Kyoko Kogawa Sato,Tomoshige Hayashi,Shinichiro Uehara,Shigeki Kinuhata,Keiko Oue,Ginji Endo,Hiroshi Kambe,Kanji Fukuda,Tomoyuki Kawada,Mae Thamer,Yi Zhang,James S. Kaufman,Onkar Kshirsagar,Dennis J. Cotter,Miguel A. Hernán,Chie Ogawa,Ken Tsuchiya,Fumiyoshi Kanda,Teiryo Maeda,Jay A. White,Joel Z. Melnick,Charles W. Bishop,Xiaoyan Bai,Jian Geng,Xiao Li,Fang Yang,Jianwei Tian,Teresa Arcidiacono,Alessandra Mingione,Lorenza Macrina,Francesca Pivari,Laura Soldati,Giuseppe Vezzoli,Jenise Stephen,Teresa L. Anderson-Haag,Sally K. Gustafson,Jon J. Snyder,Bertram L. Kasiske,Ajay K. Israni,Stuart M. Sprague,Arnold L. Silva,Fahd Al-Saghir,Radhika Damle,Samir P. Tabash,Martin Petkovich,Eric J. Messner,Satz Mengensatzproduktion,Druckerei Stückle +76 more
TL;DR: The aim of this work is to contribute towards the humanizing of endocrinology by promoting awareness of the importance ofocrinology in the care and treatment of patients withocrine-related illnesses.
Patent
Préparation combinée comprenant de la finérénone et du valsartan
TL;DR: La presente invention concerne l'utilisation de l'agoniste du recepteur mineralocorticoide finerenone en combinaison avec le Valsartan, un agoniste de l-angiotensine AII, pour traiter et/ou prevenir des troubles du systeme cardiovasculaire, des troubles renaux, des problems pulmonaires and pour traiting et/u prevenIR des troubles fibrotiques.
Journal ArticleDOI
Pos-350 finerenone in mild to severe chronic kidney disease and type 2 diabetes: the fidelity prespecified pooled analysis
Peter Rossing,Rajani R Agarwal,S.D. Anker,Gerasimos Filippatos,Bertram Pitt,Luis M. Ruilope,Amer Joseph,Martin Gebel,Peter Kolkhof,Christina Nowack,George L. Bakris +10 more
TL;DR: In this article , the authors evaluated the effects of finerenone on composite kidney and cardiovascular endpoints in varying stages of CKD (defined by estimated glomerular filtration rate [eGFR] and urine albumin-to-creatinine ratio [UACR]).